H
Loading...
Loading...
CDC PLACES does not publish a city-level diabetes row for Louisville. Use the national 12% (CDC National Diabetes Statistics Report) plus your own panel — do not invent a local rate. Census population 628,594. Kentucky Medicare wound biologics: CGS Administrators (J15). Hawk Medical is a national HCT/P 361 and wound-care distributor serving licensed Louisville clinics — not a walk-in office.
Written for licensed providers. Reviewed by Joe Bradley, Founder & CEO. Content version 2026-09-18. Hawk Medical ships nationwide — this is not a Louisville storefront.
Fibrin Matrix Therapy Products in Louisville, KY for clinics & physicians. Fibrin matrix therapy supports… Compliance support & pricing — contact Hawk Medical.
We do not have a CDC PLACES uninsured rate for Louisville. Expect a mix of J15 fee-for-service, Advantage, workers’ comp, and cash-pay, and price them as separate tickets. CDC PLACES does not publish a city-level diabetes row for Louisville. Use the national 12% (CDC National Diabetes Statistics Report) plus your own panel — do not invent a local rate. Population 628,594. The useful question is not “do you have a warehouse on our street?” — it is whether receiving, IFUs, and J15 documentation are ready before the first application of fibrin matrix therapy.
National Fibrin Matrix Therapy Products notes (how the product actually works)Kentucky shares J15 with OH. Florida is the only single-state MAC. CDC PLACES does not publish a city-level diabetes row for Louisville. Use the national 12% (CDC National Diabetes Statistics Report) plus your own panel — do not invent a local rate. If you also operate in another contractor’s state, say so on the first call — we map both.
The 96.5% hematogel figure on our wound materials is product-level clinical experience, not a Louisville trial. Local outcomes stay with the treating physician. CDC PLACES does not publish a city-level diabetes row for Louisville. Use the national 12% (CDC National Diabetes Statistics Report) plus your own panel — do not invent a local rate. Use that rate for inventory math, not for ads.
CDC PLACES has no incorporated-place row we could match for Louisville. We will not interpolate one from the state BRFSS range. Use the national 12% (CDC) plus your panel.
We distribute nationwide. Transit time depends on carrier and SKU, not on a fictional local warehouse. Ask for current lead times on the specific centrifuge, allograft, or CTP you intend to bill.
The allograft is used to perform the same basic function in the recipient as in the donor (FDA 361). Using umbilical or amniotic tissue as a marketed “stem cell cure” for unrelated conditions is outside that lane and is a Kentucky compliance risk.
The 96.5% figure is a product-level clinical experience statistic published on our wound-care materials — not a city-specific trial. Your outcomes will depend on patient selection, offloading, and follow-up.
Bring specialty, monthly wound volume, and whether you bill J15 FFS, Advantage, workers’ comp, or cash-pay. PLACES has no city row here; bring your own panel mix. Book 15 minutes with Joe or use the contact form.
Contact us to learn how Hawk Medical supports practices in Louisville, KY.
Hawk Medical is a national distributor. Joe Bradley’s clinic uses the same product classes. What is local for Louisville is J15 geography and published epidemiology — not a street address.
No PLACES city row. National CDC 12% is the floor until you use your own panel.
Kentucky Part B wound biologics follow this contractor (siblings: OH). We train to the articles. We do not write coverage.
City-proper population is scale for a city of 500k–1M, not a count of orthopedic groups.
No Louisville storefront. Joe Bradley is an active practice owner. fibrin matrix therapy stays in its regulatory lane — not “FDA-approved stem cell therapy.”
Experience the difference of working with a distributor who understands your practice because we operate one ourselves.